TNP-ATP triethylammonium

Cat. No.: HY-108667 Purity: 98.7%: FAQs
Data Sheet SDS COA Handling Instructions Technical Support

TNP-ATP triethylammonium is a selective P2X receptor antagonist. TNP-ATP triethylammonium shows antinociceptive effects in rats.

For research use only. We do not sell to patients.

TNP-ATP triethylammonium Chemical Structure

CAS No. : 61368-63-6

Size	Price	Stock	Quantity
Solvent
1 mg (10 mM * 89.05 μL in Water)		In-stock	Estimated Time of Arrival: December 31

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All P2X Receptor Isoform Specific Products:

View All Isoforms

P2X1 Receptor P2X2 Receptor P2X3 Receptor P2X4 Receptor P2X7 Receptor

Biological Activity
Purity & Documentation
References
Customer Review

Description	TNP-ATP triethylammonium is a selective P2X receptor antagonist. TNP-ATP triethylammonium shows antinociceptive effects in rats^[1].
Molecular Weight	1123.03
Formula	C₄₀H₇₇N₁₂O₁₉P₃
CAS No.	61368-63-6
Appearance	Liquid
Color	Orange to red
SMILES	CCN(CC)CC.CCN(CC)CC.CCN(CC)CC.CCN(CC)CC.NC1=NC=NC2=C1N=CN2[C@H](O3)[C@H](O4)[C@H](OC54C([N+]([O-])=O)=CC([N+]([O-])=O)=CC5[N+]([O-])=O)[C@H]3COP(O)(OP(OP(O)(O)=O)(O)=O)=O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	-20°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
Purity & Documentation	Purity: 98.7% Select Batch: Data Sheet (267 KB) SDS (252 KB) COA (251 KB) Handling Instructions (2659 KB)
References	[1]. Jarvis MF, et al. Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue. Br J Pharmacol. 2001 Jan;132(1):259-69. [Content Brief]